This article is more than 5 years old. Information may no longer be current.

EOS Imaging receives FDA 510(k) clearance to market 3-D planning software for TKA

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

EOS Imaging announced it received FDA 510(k) clearance to market its kneeEOS software in the United States.

According to a company release, the online 3-D planning software uses weight-bearing 3-D images and data from EOS system to allow for surgical planning for total knee arthroplasty. The kneeEOS reportedly makes an initial automatic proposal for component size and position. The software also optimizes alignment in 3-D and displays real-time clinical parameters.

“The kneeEOS FDA clearance is an important milestone that allows us to offer our full set of software solutions to the U.S. market,” Marie Meynadier, chief executive officer of EOS Imaging, said in the release. “It will support the growing adoption of EOS images, 3-D models and patient-specific datasets at each step of the care continuum, helping health care providers bring the value of personalized treatments to their patients without the high dose and cost of CT imaging.”

Reference:

www.eos-imaging.com